- PRESCRIBING INFORMATION AND ADVERSE EVENTS REPORTING
- IMBRUVICA® (IBRUTINIB)
- DARZALEX® (DARATUMUMAB) and VELCADE® (BORTEZOMIB)
In our podcast series, some of the UK’s leading haematologists share their patient stories, clinical updates and expert opinions.
Listen to the podcasts below (Internet connection required).
Subscribing to this podcast series via Apple Podcasts will subscribe you to all subsequent episodes in the series, and you will be notified when new content becomes available. You will have direct access to this content via the Apple Podcasting application.
Dr. Rebecca Auer, of Bart's Hospital, discusses the role of allografting in Mantle Cell Lymphoma.
This item contains references to Janssen products.
Imbruvica® (Ibrutinib) prescribing information & adverse events reporting can be found here.
Subscribing to this podcast series via Apple Podcasts will subscribe you to all subsequent episodes in the series, and you will be notified when new content becomes available. You will have direct access to this content via your chosen podcast application.
Content Date of Preparation: June 2020
Item Code: CP-101042
Content Date of Preparation: June 2020
Item Code: CP-101042